CSF2 and cancer: The ability of GM-CSF to stimulate the proliferation of activated CD54+ neutrophils has also been described, which may be useful for immunotherapy, since neutropenia is one of the most common symptoms of cytokine-based immunotherapy in cancer patients (Yu and Hua, 2018).